Menopause and treatments

@article{Ringa2004MenopauseAT,
  title={Menopause and treatments},
  author={Virginie Ringa},
  journal={Quality of Life Research},
  year={2004},
  volume={9},
  pages={695-707}
}
  • V. Ringa
  • Published 2004
  • Medicine
  • Quality of Life Research
Postmenopausal women comprise close to 10% of the world population. Their quality of life can be affected by menopausal symptoms or diseases associated with the postmenopausal period and by the effects, beneficial or negative, of curative or preventive therapies prescribed for these disorders. Many symptoms have been reported to be associated with menopause, but the question still remains of which are attributable to menopause and which to other causes. Osteoporosis and cardiovascular diseases… 
Hormone Therapy for the Management of Menopausal Symptoms
TLDR
HT may be a reasonable pharmacotherapy option for the management of menopausal symptoms following complete patient evaluation by experienced clinicians and Updated recommendations addressing management ofMenopausal symptoms, a new HT product containing the spironolactone-analogue drospirenone (DRSP), and discontinuation methods of HT are discussed.
Novel Lipid Indices as a Better Marker of Cardiovascular Disease Risk in Postmenopausal Women
TLDR
This study has been undertaken on the role of various lipid indices like Atherogenic Index of Plasma (AIP), Castelli Risk Index I and II, non-HDL cholesterol (NHDL-C), and atherogenic coefficient (AC) in assessing the risk of CVD in postmenopausal women with the following objectives.
Anxiety in Natural and Surgical Menopause — Physiologic and Therapeutic Bases
TLDR
The participation of ovarian hormones in the regulation of emotional and affective disorders in women with natural or surgical menopause is reviewed; particularly their anatomical pathways, neurotransmission systems, and the resulting behavioural patterns.
Symptoms during Menopausal Transition: Age at Onset, Prevalence and Burden among Women in Delta State, Nigeria
The menopausal phase of life is not a disease but a phase of gradual decline in ovarian function in women’s life. This phase of life is physiological and associated with physical, psychosocial and
Examining the Relationship between Inflammatory Markers and Menopausal Status in Breast Cancer Patients Undergoing Chemotherapy Treatment
TLDR
It is indicated that menopausal status does not account for the variability observed in inflammatory biomarker data in women with breast cancer prior to or following chemotherapy.
Exercise in Menopausal Women
TLDR
Data suggests that women who participate in regular exercise experience less menopausal symptoms than those who do not; therefore exercise may present a safe and accessible therapy for the symptoms of menopause, and the need for more well-designed, appropriately powered studies in the future is highlighted.
Menopause: A Contextualized Experience Across Social Structures
Menopause is a phenomenon experienced by women as they approach middle age, marking the end of menstruation and reproduction. Throughout history, menopause has been classified in negative terms as a
The Study of Plasma Homocysteine and Lipid Profile Levels as Markers of Cardiovascular Disease in Pre and Postmenopausal Women
TLDR
There is a significant increase in homocysteine levels than lipid profile parameters, hence homocy steine may be consider as a sensitive marker of CVD’s in postmenopausal women.
Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan
TLDR
Not only patients ≥50 years but also younger patients with tamoxifen treatment had higher risk of subsequent endometrial cancer in this nation-wide cohort and regular gynecologic monitoring is suggested not only during active use but also during follow-up phase.
To exercise, or, not to exercise, during menopause and beyond.
Menopausal symptoms in women can be severe and disruptive to overall quality of life. Hormone replacement therapy, is known to be effective in ameliorating symptoms, however, reporting of side
...
1
2
3
...

References

SHOWING 1-10 OF 124 REFERENCES
The menopause
TLDR
Overall, based on observational studies, postmenopausal women who use hormones have a 30-50% lower all-cause mortality rate than those who do not use hormones.
Hormone replacement therapy: the perspectives for the 21st century.
TLDR
HRT can be offered either as a preventive tool or as individualized care on the basis of personal needs, and new therapeutic options like the SERMs will offer a substantial medical advancement for the treatment of postmenopausal women.
Hormone replacement therapy
TLDR
Routine oestrogen treatment should not be recommended until more risk:benefit data are available from clinical trials, based on observations during 25 years of research into women's health, and on Medline searches on oestrogens or menopause.
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women.
TLDR
Evidence from epidemiological studies indicates that estrogen replacement therapy in postmenopausal women can reduce their risk of coronary heart disease and the effect of progestin added to estrogen therapy has not been adequately assessed, but initial evidence suggests that it may somewhat attenuate, although not completely eliminate, the benefits of estrogen on cardiovascular disease.
Compliance with hormone therapy.
  • V. Ravnikar
  • Medicine
    American journal of obstetrics and gynecology
  • 1987
TLDR
Noncompliance, stemming from side effects or the problem of forgetting to take medications, can be improved through the use of the transdermal estrogen formulation, and any problems with unscheduled bleeding or hyperplasia can be circumvented through the addition of progestogens.
Menopause and the risk of coronary heart disease in women.
TLDR
Data suggest that, in contrast to a natural menopause, bilateral oophorectomy increases the risk of coronary heart disease, and this increase appears to be prevented by estrogen-replacement therapy.
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
TLDR
The addition of progestins to estrogen therapy does not reduce the risk of breast cancer among postmenopausal women and the substantial increase in the risk among older women who take hormones suggests that the trade-offs between risks and benefits should be carefully assessed.
Menopause and risk of cardiovascular disease: the Framingham study.
TLDR
Although cholesterol and hemoglobin did rise somewhat more steeply in women undergoing the menopause, this greater incidence of cardiovascular disease in postmenopausal women could not be explained by the influence of theMenopause on the usual cardiovascular risk factors.
Quality of life after the menopause: influence of hormonal replacement therapy.
TLDR
The effect of hormone replacement therapy on the quality of life of postmenopausal women was significantly superior to symptomatic treatment.
An Assessment of Hormone Replacement Therapy to Prevent Postmenopausal Osteoporosis
TLDR
Evidence indicates that the postmenopausal decline in estradiol synthesis may be responsible not only for the more rapid bone loss in early menopause but also for the slower phase of bone loss at older age, suggesting strategies to reduce the incidence of low bone mass and subsequent fragility fractures are of pivotal importance.
...
1
2
3
4
5
...